OLMEGRAN HCT (20 + 12,5) MG COM REV CT BL AL AL X 20
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1677306480028 -
GGREM
538820090086007 -
Código de barras
7896004773636
O que a fonte publica
- Detentor do registro
- LEGRAND PHARMA INDUSTRIA FARMACEUTICA LTDA
- Princípios ativos
- HIDROCLOROTIAZIDA;OLMESARTANA MEDOXOMILA
- Embalagem
- (20 + 12,5) MG COM REV CT BL AL AL X 20
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- OLMEGRAN HCT (20 + 12,5) MG COM REV CT BL AL AL X 20
- OLMEGRAN HCT
- HIDROCLOROTIAZIDA
- OLMESARTANA MEDOXOMILA
Dados completos da fonte
{
"name": "OLMEGRAN HCT (20 + 12,5) MG COM REV CT BL AL AL X 20",
"holder": "LEGRAND PHARMA INDUSTRIA FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004773636"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "538820090086007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.044.984/0001-26",
"priceRegime": "Regulado",
"productName": "OLMEGRAN HCT",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "(20 + 12,5) MG COM REV CT BL AL AL X 20",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "40.45",
"icms-12": "45.97",
"icms-17": "48.73",
"icms-18": "49.33",
"icms-19": "49.94",
"icms-20": "50.56",
"icms-21": "51.20",
"icms-22": "51.86",
"icms-23": "52.53",
"icms-17.5": "49.03",
"icms-19.5": "50.25",
"icms-20.5": "50.88",
"icms-22.5": "52.19",
"icms-12-alc": "45.41",
"icms-17-alc": "48.15",
"icms-18-alc": "48.74",
"icms-19-alc": "49.34",
"icms-20-alc": "49.96",
"icms-21-alc": "50.59",
"icms-22-alc": "51.24",
"icms-23-alc": "51.90",
"withoutTaxes": "39.96",
"icms-17.5-alc": "48.44",
"icms-19.5-alc": "49.65",
"icms-20.5-alc": "50.27",
"icms-22.5-alc": "51.57"
},
"pisCofinsList": "Positiva",
"substanceText": "HIDROCLOROTIAZIDA;OLMESARTANA MEDOXOMILA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "55.76",
"icms-12": "63.36",
"icms-17": "67.17",
"icms-18": "68.00",
"icms-19": "68.84",
"icms-20": "69.69",
"icms-21": "70.57",
"icms-22": "71.48",
"icms-23": "72.41",
"icms-17.5": "67.58",
"icms-19.5": "69.26",
"icms-20.5": "70.13",
"icms-22.5": "71.94",
"icms-12-alc": "62.78",
"icms-17-alc": "66.56",
"icms-18-alc": "67.38",
"icms-19-alc": "68.21",
"icms-20-alc": "69.07",
"icms-21-alc": "69.94",
"icms-22-alc": "70.84",
"icms-23-alc": "71.75",
"withoutTaxes": "55.25",
"icms-17.5-alc": "66.97",
"icms-19.5-alc": "68.64",
"icms-20.5-alc": "69.50",
"icms-22.5-alc": "71.29"
},
"invalidBarcodes": [],
"activeSubstances": [
"HIDROCLOROTIAZIDA",
"OLMESARTANA MEDOXOMILA"
],
"therapeuticClass": "C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1677306480028",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:538820090086007"